Enjoy complimentary customisation on priority with our Enterprise License!
The hormonal contraceptive market share is expected to increase by USD 5.24 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.30%.
This hormonal contraceptives market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers hormonal contraceptives market segmentation by method (oral contraceptives, implanted contraceptives, injected contraceptives, intrauterine, and others) and geography (North America, Asia, Europe, and ROW). The hormonal contraceptives market report also offers information on several market vendors, including AbbVie Inc., Afaxys Pharma LLC, Bayer AG, HLL Lifecare Ltd., Johnson and Johnson Inc., Lupin Ltd., Merck and Co. Inc., Mylan NV, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. among others.
Download the Free Report Sample to Unlock the Hormonal Contraceptives Market Size for the Forecast Period and Other Important Statistics
Hormonal methods of birth control (contraception) contain either estrogen and progestin or progestin-only they are a safe and reliable way to prevent pregnancy for most people. Hormonal methods include an implant, an intrauterine device (IUD), injections, pills, vaginal rings, and skin patches. It is be taken in mouth, injected or inserted under the skin, placed on the skin as a patch, or placed in the vagina or uterus.
The increase in unplanned pregnancies is notably driving the hormonal contraceptives market growth, although factors such as lack of social acceptance may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the hormonal contraceptives industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Hormonal Contraceptives Market Driver
One of the key factors driving the global hormonal contraceptives market growth is the increase in unplanned pregnancies. Governments worldwide have been making efforts to tackle the issue of unplanned pregnancies, but their initiatives have been undermined by public healthcare cuts. Also, the rising prevalence of unprotected sex among the young generation has increased the number of unplanned pregnancies. Furthermore, in the case of an unplanned pregnancy, a woman may not be in optimal health for childbearing and eventually child-rearing, thus affecting the health of the baby. For instance, between 2015 and 2020, globally, there were 121 million unintended pregnancies annually, corresponding to a global rate of 64 pregnancies per 1,000 women aged 15-49 years. With the rise in the number of unplanned pregnancies, the demand for hormonal contraceptives is expected to increase, thus propelling sales for vendors and leading to market growth.
Key Hormonal Contraceptives Market Trend
Another key factor driving the global hormonal contraceptives market growth is the growing awareness about the importance of family planning in developing countries. Voluntary family planning has been widely adopted across the world through the efforts of the media and governments. Organizations like the Asia-Pacific Council on Contraception, the European Society of Cardiology, and the International Planned Parenthood Federation conduct programs to spread awareness about contraceptives, such as hormonal contraceptives worldwide. However, in developing countries, there is a huge unmet need for contraception. Thus, the market is expected to grow during the forecast period, which will be further supported by government initiatives that promote family planning and provide women with easy access to contraceptives.
Key Hormonal Contraceptives Market Challenge
One of the key challenges to the global hormonal contraceptives market growth is the lack of social acceptance due to stereotypes. The perception of society dissuades people from buying these products. Most societies, due to their religious values, believe hormonal contraceptives to be immoral and unethical. Although the emergence of e-commerce has helped overcome this hurdle, as it provides buyers anonymity, the perception of the society remains the same. Such factors will affect the sales of hormonal contraceptives, which will impact the growth of the market in focus during the forecast period.
This hormonal contraceptives market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global hormonal contraceptives market as a part of the global pharmaceutical market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the hormonal contraceptives market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the hormonal contraceptives market encompasses successful business strategies deployed by the key vendors. The hormonal contraceptives market is fragmented and the vendors are deploying growth strategies such as investment in R&D and product innovation to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The hormonal contraceptives market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the hormonal contraceptives market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chains is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the global pharmaceutical market includes the following core components:
The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.
For more insights on the market share of various regions Request for a FREE sample now!
34% of the market's growth will originate from North America during the forecast period. Mexico, the US, Dominican Republic, and Canada are the key markets for hormonal contraceptives in North America. Market growth in this region will be slower than the growth of the market in Europe and Asia.
The presence of local market players, supportive government policies, and technological innovations will facilitate the hormonal contraceptives market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
In 2020, the outbreak of COVID-19 affected all countries in North America. A rise in the number of COVID-19 cases in the first quarter of 2020 led to partial lockdowns in several countries, including Canada and Mexico. Hence, the adoption of some hormonal contraceptives, including related procedures, and the availability of prescription drugs reduced slightly, which impacted market growth in 2020 and in Q1 of 2021 to some extent. However, by the second half of 2020, most of the restrictions in various countries had been relaxed to some extent, which allowed business activities and essential services, including the sales of OTC contraceptives, to resume. The relaxation of such restrictions has encouraged people to go for health checkups and treatments, which will drive the growth of the hormonal contraceptives market in North America during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The hormonal contraceptive market share growth by the oral contraceptives segment will be significant during the forecast period. The high demand for oral contraceptives will drive the market growth through this segment. Approximately 25% of women aged 15 to 44 who currently use contraception prefer using the birth control pill as their method of choice.
This report provides an accurate prediction of the contribution of all the segments to the growth of the hormonal contraceptives market size and actionable market insights on post COVID-19 impact on each segment.
Hormonal Contraceptives Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.30% |
Market growth 2022-2026 |
$ 5.24 billion |
Market structure |
Fragmented |
YoY growth (%) |
3.74 |
Regional analysis |
North America, Asia, Europe, and ROW |
Performing market contribution |
North America at 34% |
Key consumer countries |
Mexico, US, Dominican Republic, India, and Canada |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
AbbVie Inc., Afaxys Pharma LLC, Bayer AG, HLL Lifecare Ltd., Johnson and Johnson Inc., Lupin Ltd., Merck and Co. Inc., Mylan NV, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
***1. Executive Summary
**1.1 Market Overview
*Exhibit 01: Key Finding 1
*Exhibit 02: Key finding 2
*Exhibit 03: Key finding 3
*Exhibit 04: Key finding 5
*Exhibit 05: Key finding 6
*Exhibit 06: Key finding 7
*Exhibit 07: Key finding 8
***2. Market Landscape
**2.1 Market ecosystem
*2.1.1 Parent market
*Exhibit 08: Parent market
*Exhibit 09: Market characteristics
**2.2 Value chain analysis
*Exhibit 10: Value chain analysis: Electronic equipment and instruments
*2.2.1 Research and development (R&D) and drug discovery
*2.2.2 Integration and product development
*2.2.3 Manufacturing
*2.2.4 Outbound logistic
*2.2.5 Marketing and sales
*2.2.6 Support services
*2.2.7 Innovation
***3. Market Sizing
**3.1 Market definition
*Exhibit 11: Offerings of vendors included in the market definition
**3.2 Market segment analysis
*Exhibit 12: Market segments
**3.3 Market size 2021
**3.4 Market outlook: Forecast for 2021 - 2026
*3.4.1 Estimating growth rates for emerging and high-growth markets
*3.4.2 Estimating growth rates for mature markets
*Exhibit 13: Global - Market size and forecast 2021 - 2026 ($ million)
*Exhibit 14: Global market: Year-over-year growth 2021 - 2026 (%)
***4. Five Forces Analysis
**4.1 Five Forces Summary
*Exhibit 15: Five forces analysis 2021 & 2026
**4.2 Bargaining power of buyers
*Exhibit 16: Bargaining power of buyers
**4.3 Bargaining power of suppliers
*Exhibit 17: Bargaining power of suppliers
**4.4 Threat of new entrants
*Exhibit 18: Threat of new entrants
**4.5 Threat of substitutes
*Exhibit 19: Threat of substitutes
**4.6 Threat of rivalry
*Exhibit 20: Threat of rivalry
**4.7 Market condition
*Exhibit 21: Market condition - Five forces 2021
***5. Market Segmentation by Method
**5.1 Market segments
*The segments covered in this chapter are:
*Exhibit 22: Method - Market share 2021-2026 (%)
**5.2 Comparison by Method
*Exhibit 23: Comparison by Method
**5.3 Oral contraceptives - Market size and forecast 2021-2026
*Exhibit 24: Oral contraceptives - Market size and forecast 2021-2026 ($ million)
*Exhibit 25: Oral contraceptives - Year-over-year growth 2021-2026 (%)
**5.4 Implanted contraceptives - Market size and forecast 2021-2026
*Exhibit 26: Implanted contraceptives - Market size and forecast 2021-2026 ($ million)
*Exhibit 27: Implanted contraceptives - Year-over-year growth 2021-2026 (%)
**5.5 Injected contraceptives - Market size and forecast 2021-2026
*Exhibit 28: Injected contraceptives - Market size and forecast 2021-2026 ($ million)
*Exhibit 29: Injected contraceptives - Year-over-year growth 2021-2026 (%)
**5.6 Intrauterine - Market size and forecast 2021-2026
*Exhibit 30: Intrauterine - Market size and forecast 2021-2026 ($ million)
*Exhibit 31: Intrauterine - Year-over-year growth 2021-2026 (%)
**5.7 Others - Market size and forecast 2021-2026
*Exhibit 32: Others - Market size and forecast 2021-2026 ($ million)
*Exhibit 33: Others - Year-over-year growth 2021-2026 (%)
**5.8 Market opportunity by Method
*Exhibit 34: Market opportunity by Method
***6. Customer landscape
*Technavio’s customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria
**6.1 Customer landscape
*Exhibit 35: Customer landscape
***7. Geographic Landscape
**7.1 Geographic segmentation
*The regions covered in the report are:
*Exhibit 36: Market share by geography 2021-2026 (%)
**7.2 Geographic comparison
*Exhibit 37: Geographic comparison
**7.3 North America - Market size and forecast 2021-2026
*Exhibit 38: North America - Market size and forecast 2021-2026 ($ million)
*Exhibit 39: North America - Year-over-year growth 2021-2026 (%)
**7.4 Asia - Market size and forecast 2021-2026
*Exhibit 40: Asia - Market size and forecast 2021-2026 ($ million)
*Exhibit 41: Asia - Year-over-year growth 2021-2026 (%)
**7.5 Europe - Market size and forecast 2021-2026
*Exhibit 42: Europe - Market size and forecast 2021-2026 ($ million)
*Exhibit 43: Europe - Year-over-year growth 2021-2026 (%)
**7.6 ROW - Market size and forecast 2021-2026
*Exhibit 44: ROW - Market size and forecast 2021-2026 ($ million)
*Exhibit 45: ROW - Year-over-year growth 2021-2026 (%)
**7.7 Key leading countries
*Exhibit 46: Key leading countries
**7.8 Market opportunity by geography
*Exhibit 47: Market opportunity by geography ($ million)
***8. Drivers, Challenges, and Trends
**8.1 Market drivers
*8.1.1 Increase in unplanned pregnancies
*8.1.2 Initiatives by government and non-profit organizations
*8.1.3 Increasing adoption of innovative marketing strategies
**8.2 Market challenges
*8.2.1 Lack of social acceptance
*8.2.2 Disparities with regard to sex education in developed countries
*8.2.3 Lack of reimbursement
*Exhibit 48: Impact of drivers and challenges
**8.3 Market trends
*8.3.1 Importance of family planning in developing countries
*8.3.2 Rising disposable income
*8.3.3 Technological advances
***9. Vendor Landscape
**9.1 Overview
*Exhibit 49: Vendor landscape
**9.2 Landscape disruption
*Exhibit 50: Landscape disruption
*Exhibit 51: Industry risks
**9.3 Competitive landscape
***10. Vendor Analysis
**10.1 Vendors covered
*Exhibit 52: Vendors covered
**10.2 Market positioning of vendors
*Exhibit 53: Market positioning of vendors
**10.3 AbbVie Inc.
*Exhibit 54: AbbVie Inc. - Overview
*Exhibit 55: AbbVie Inc. - Business segments
*Exhibit 56: AbbVie Inc. - Key offerings
*Exhibit 57: AbbVie Inc. - Segment focus
**10.4 Afaxys Pharma LLC
*Exhibit 58: Afaxys Pharma LLC - Overview
*Exhibit 59: Afaxys Pharma LLC - Product and service
*Exhibit 60: Afaxys Pharma LLC - Key offerings
**10.5 Bayer AG
*Exhibit 61: Bayer AG - Overview
*Exhibit 62: Bayer AG - Business segments
*Exhibit 63: Bayer AG - Key offerings
*Exhibit 64: Bayer AG - Segment focus
**10.6 HLL Lifecare Ltd.
*Exhibit 65: HLL Lifecare Ltd. - Overview
*Exhibit 66: HLL Lifecare Ltd. - Product and service
*Exhibit 67: HLL Lifecare Ltd. - Key offerings
**10.7 Johnson and Johnson Inc.
*Exhibit 68: Johnson and Johnson Inc. - Overview
*Exhibit 69: Johnson and Johnson Inc. - Business segments
*Exhibit 70: Johnson and Johnson Inc. - Key offerings
*Exhibit 71: Johnson and Johnson Inc. - Segment focus
*10.8 Lupin Ltd.
*Exhibit 72: Lupin Ltd. - Overview
*Exhibit 73: Lupin Ltd. - Product and service
*Exhibit 74: Lupin Ltd. - Key offerings
**10.9 Merck and Co. Inc.
*Exhibit 75: Merck and Co. Inc. - Overview
*Exhibit 76: Merck and Co. Inc. - Business segments
*Exhibit 77: Merck and Co. Inc. - Key offerings
*Exhibit 78: Merck and Co. Inc. - Segment focus
**10.10 Mylan NV
*Exhibit 79: Mylan NV - Overview
*Exhibit 80: Mylan NV - Business segments
*Exhibit 81: Mylan NV - Key offerings
*Exhibit 82: Mylan NV - Segment focus
**10.11 Pfizer Inc.
*Exhibit 83: Pfizer Inc. - Overview
*Exhibit 84: Pfizer Inc. - Key offerings
*Exhibit 85: Pfizer Inc. - Segment focus
**10.12 Teva Pharmaceutical Industries Ltd.
*Exhibit 86: Teva Pharmaceutical Industries Ltd. - Overview
*Exhibit 87: Teva Pharmaceutical Industries Ltd. - Business segments
*Exhibit 88: Teva Pharmaceutical Industries Ltd. - Key offerings
*Exhibit 89: Teva Pharmaceutical Industries Ltd. - Segment focus
***11. Appendix
**11.1 Scope of the report
*11.1.1 Market definition
*11.1.2 Objectives
*11.1.3 Notes and caveats
**11.2 Currency conversion rates for US$
*Exhibit 90: Currency conversion rates for US$
**11.3 Research Methodology
*Exhibit 91: Research Methodology
*Exhibit 92: Validation techniques employed for market sizing
*Exhibit 93: Information sources
**11.4 List of abbreviations
*Exhibit 94: List of abbreviations
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.